Topiramato / Topiramate
Bibliografía en Revistas Internacionales de Instituciones Españolas
Using topiramate or naltrexone for the treatment of alcohol-dependent patients.
Alcohol Clin Exp Res. 2008 Jul;32(7):1251-9. Florez G., Garcia-Portilla P., Alvarez S., Saiz P.A., Nogueiras L., Bobes J.
Topiramate in the prophylactic treatment of migraine in children.
J Child Neurol. 2005 Mar;20(3):251-3. Campistol J., Campos J., Casas C., Herranz J.L.
Adjunctive topiramate in bipolar II disorder.
World J Biol Psychiatry. 2003 Oct;4(4):172-6. Vieta E., Sanchez-Moreno J., Goikolea J.M., Torrent C., Benabarre A., Colom F., Martinez-Aran A., Reinares M., Comes M., Corbella B.
Effects of topiramate in the treatment of alcohol dependence.
Pharmacopsychiatry. 2004 Jan;37(1):37-40. Rubio G., Ponce G., Jimenez-Arriero M.A., Palomo T., Manzanares J., Ferre F.
Topiramate serum concentration-to-dose ratio: influence of age and concomitant antiepileptic drugs and monitoring implications.
Ther Drug Monit. 2004 Jun;26(3):251-7. Adin J., Gomez M.C., Blanco Y., Herranz J.L., Armijo J.A.
Topiramate-responsive headache due to idiopathic intracranial hypertension in Behcet syndrome.
Headache. 2004 May;44(5):436-7. Palacio E., Rodero L., Pascual J.
Topiramate as treatment for hemifacial spasm.
Clin Neuropharmacol. 2007 Sep-Oct;30(5):308-9. Alonso-Navarro H., Rubio L., Jimenez-Jimenez F.J.
How many migraine patients need prolonged (>1 year) preventive treatment? Experience with topiramate.
J Headache Pain. 2007 Apr;8(2):90-3. Epub 2007 Jan 15. Pascual J., El B., Gomez-Sanchez J.C.
Time course of adverse events most commonly associated with topiramate for migraine prevention.
Eur J Neurol. 2007 Aug;14(8):900-6. Lainez M.J., Freitag F.G., Pfeil J., Ascher S., Olson W.H., Schwalen S.
Testing the combination beta-blocker plus topiramate in refractory migraine.
Acta Neurol Scand. 2007 Feb;115(2):81-3. Pascual J., Rivas M.T., Leira R.
Impact of preventive therapy with nadolol and topiramate on the quality of life of migraine patients.
Cephalalgia. 2007 Aug;27(8):920-8. Epub 2007 Jul 23. Garcia-Monco J.C., Foncea N., Bilbao A., Ruiz , Gomez-Beldarrain M.
Primary cough headache responsive to topiramate.
Cephalalgia. 2005 Aug;25(8):627-8. Medrano V., Mallada J., Sempere A.P., Fernandez S., Piqueras L.
Topiramate as add-on therapy in non-respondent alcohol dependant patients: a 12 month follow-up study.
Actas Esp Psiquiatr. 2007 Jul-Aug;35(4):236-42. Fernandez M., Marina G., Montes P., Diaz G., Gutierrez C., Antuna D., Bobes G.
Reversible tremor, myoclonus, and fasciculations associated with topiramate use for migraine.
Clin Neuropharmacol. 2006 May-Jun;29(3):157-9. Alonso-Navarro H., Jimenez-Jimenez F.J.
Effects on weight and outcome of long-term olanzapine-topiramate combination treatment in bipolar disorder.
J Clin Psychopharmacol. 2004 Aug;24(4):374-8. Vieta E., Sanchez-Moreno J., Goikolea J.M., Colom F., Martinez-Aran A., Benabarre A., Corbella B., Torrent C., Comes M., Reinares M., Brugue E.
Antiepileptic drugs for the treatment of chronic and episodic cluster headache: a review.
Headache. 2007 Jan;47(1):81-9. Pascual J., Lainez M.J., Dodick D., Hering-Hanit R.
Association between the Stin2 VNTR polymorphism of the serotonin transporter gene and treatment outcome in alcohol-dependent patients.
Alcohol Alcohol. 2008 Sep-Oct;43(5):516-22. Epub 2008 Jun 14. Florez G., Saiz P., Garcia-Portilla P., Alvarez S., Nogueiras L., Morales B., Alvarez V., Coto E., Bobes J.
Randomized dose-controlled study of topiramate as first-line therapy in epilepsy.
Acta Neurol Scand. 2005 Oct;112(4):214-22. Arroyo S., Dodson W.E., Privitera M.D., Glauser T.A., Naritoku D.K., Dlugos D.J., Wang S., Schwabe S.K., Twyman R.E.
Effectiveness of topiramate for tobacco dependence in patients with depression; a randomised, controlled trial.
BMC Fam Pract. 2008 May 7;9:28. Campayo J.G., Sobradiel N., Alda M., Mas A., Andres E., Magallon R., Crucelaegui A., Sanz B.
Antiaggressive effects of topiramate in agonistic encounters between male mice.
Methods Find Exp Clin Pharmacol. 2007 Apr;29(3):195-8. Navarro J.F., Buron E., Martin-Lopez M.